Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.

Farrell, Christopher; Shi, Wenyin; Bodman, Alexa; Olson, Jeffrey J

Farrell, Christopher; Shi, Wenyin; Bodman, Alexa; Olson, Jeffrey J.

Affiliation

Farrell C; Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA.
Shi W; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
Bodman A; Austin Brain and Spine, Austin, TX, USA.
Olson JJ; Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, USA. jolson@emory.edu.

J Neurooncol ; 150(2): 269-359, 2020 Nov.

Article in En | MEDLINE | ID: mdl-33215345

Subject(s)

Biomarkers, Tumor/genetics; Evidence-Based Practice/standards; Glioblastoma/therapy; Multimodal Imaging/methods; Practice Guidelines as Topic/standards; Combined Modality Therapy; Disease Management; Glioblastoma/diagnosis; Glioblastoma/diagnostic imaging; Glioblastoma/genetics; Humans

Key words

Chemotherapy; Glioblastoma; Imaging; Immunotherapy; Neuropathology; Radiation therapy; Surgery; Targeted therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Biomarkers, Tumor / Practice Guidelines as Topic / Glioblastoma / Evidence-Based Practice / Multimodal Imaging Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Year: 2020 Type: Article

Fulltext

XML

PubMed Links

Search on Google